CBMG - セルラ―・バイオメディシン・グル―プ (Cellular Biomedicine Group Inc.) セルラ―・バイオメディシン・グル―プ

 CBMGのチャート


 CBMGの企業情報

symbol CBMG
会社名 Cellular Biomedicine Group Inc (セルラ―・バイオメディシン・グル―プ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Cellular Biomedicine Group Inc. is engaged in the development of cell therapy technologies. The Company develops cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from the goods manufacturing practices (GMP) laboratory. The Company's technology includes platforms such as Immune Cell therapy for treatment of broad range of cancers using Vaccine T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies Chimeric Antigen Receptor T cell (CAR-T) and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases with primary research and manufacturing facilities in China. The Company is focused on developing and marketing cell-based therapies based on its cellular platforms to treat serious chronic and degenerative diseases such as cancer orthopedic diseases.   セルラ―・バイオメディシン・グル―プは米国のバイオ医薬品企業。独自のセル技術を利用し、癌や変性疾患の新たな治療法の開発に従事。癌治療に腫瘍細胞特異的樹状細胞、関節疾患向けヒト脂肪由来間葉系前駆細胞、ヒト臍帯由来間葉系前駆細胞、中枢神経系疾患治療にヒト胚性運動ニュ―ロン前駆細胞およびヒト胚性神経前駆細胞を扱う。   
本社所在地 19925 Stevens Creek Blvd. Suite 100 Cupertino CA 95014 USA
代表者氏名 Terry A. Belmont テリー・A・ベルモント
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 408-973-7884
設立年月日 37043
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 125人
url www.cellbiomedgroup.com
nasdaq_url https://www.nasdaq.com/symbol/cbmg
adr_tso
EBITDA EBITDA(百万ドル) -28.33412
終値(lastsale) 17.52
時価総額(marketcap) 322722972.72
時価総額 時価総額(百万ドル) 255.27820
売上高 売上高(百万ドル) 0.30375
企業価値(EV) 企業価値(EV)(百万ドル) 220.49233
当期純利益 当期純利益(百万ドル) -46.80730
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Cellular Biomedicine Group Inc revenues decreased 20% to $128K. Net loss increased 43% to $17.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other income decrease of 83% to $94K (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.87 to -$1.03.

 CBMGのテクニカル分析


 CBMGのニュース

   Cellular Biomedicine Group Inc. Shares Near 52-Week High - Market Mover  2021/02/19 22:30:00 Kwhen Finance
Cellular Biomedicine Group Inc. shares closed today at 0.1% below its 52 week high of $19.76, giving the company a market cap of $384M. The stock is currently up 7.5% year-to-date, up 19.5% over the past 12 months, and up 14.8% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 60.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -65.7% The company's stock price performance over the past 12 months lags the peer average by -84.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cellular Biomedicine Group Inc. Shares Near 52-Week High - Market Mover  2021/02/12 22:30:00 Kwhen Finance
Cellular Biomedicine Group Inc. shares closed today at 0.1% below its 52 week high of $19.75, giving the company a market cap of $384M. The stock is currently up 7.3% year-to-date, up 16.7% over the past 12 months, and up 20.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 53.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -77.5% The company's stock price performance over the past 12 months lags the peer average by -89.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cellular Biomedicine Group Inc. Shares Close the Day 10.9% Higher - Daily Wrap  2021/01/29 22:30:00 Kwhen Finance
Cellular Biomedicine Group Inc. shares closed today 10.9% higher than it did at the end of yesterday. The stock is currently up 6.6% year-to-date, up 14.6% over the past 12 months, and up 42.0% over the past five years. Today, the Dow Jones Industrial Average fell 2.0%, and the S&P 500 fell 2.0%. Trading Activity Shares traded as high as $19.67 and as low as $17.60 this week.Shares closed 0% below its 52-week high and 7e+1% above its 52-week low.Trading volume this week was 84.4% lower than the 10-day average and 65.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 7.4% higher than its 5-day moving average, 8.0% higher than its 20-day moving average, and 7.6% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 0.7% The company's stock price performance over the past 12 months lags the peer average by -84.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 セルラ―・バイオメディシン・グル―プ CBMG Cellular Biomedicine Group Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)